A detailed history of Westbourne Investments, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Westbourne Investments, Inc. holds 1,925 shares of AMGN stock, worth $537,941. This represents 0.36% of its overall portfolio holdings.

Number of Shares
1,925
Previous 1,825 5.48%
Holding current value
$537,941
Previous $476 Million 26.08%
% of portfolio
0.36%
Previous 0.28%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 21, 2025

BUY
$258.59 - $327.36 $25,858 - $32,736
100 Added 5.48%
1,925 $600 Million
Q4 2024

Feb 14, 2025

BUY
$258.78 - $328.31 $472,273 - $599,165
1,825 New
1,825 $476 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Westbourne Investments, Inc. Portfolio

Follow Westbourne Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westbourne Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westbourne Investments, Inc. with notifications on news.